This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: Satellos Bioscience Inc.
Today announced interim clinical and biomarker data for SAT-3247 at the Muscular Dystrophy Association Clinical & Scientific Conference in Orlando, Florida. Satellos Bioscience Inc. shares T.MSCL are trading unchanged at $15.77.
